Bank of New York Mellon Corp - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 37 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2018$3,0000.0%12,8280.0%0.00%
Q3 2018$3,000
-78.6%
12,8280.0%0.00%
Q2 2018$14,000
-17.6%
12,828
-22.3%
0.00%
Q1 2018$17,000
-5.6%
16,500
+23.8%
0.00%
Q4 2017$18,000
-18.2%
13,328
+3.9%
0.00%
Q3 2017$22,000
-8.3%
12,8280.0%0.00%
Q2 2017$24,000
-88.3%
12,828
-79.4%
0.00%
Q1 2017$206,000
-17.3%
62,270
-0.1%
0.00%
Q4 2016$249,000
-30.6%
62,363
+2.2%
0.00%
Q3 2016$359,000
+3.5%
61,015
-3.8%
0.00%
Q2 2016$347,000
+157.0%
63,447
+124.5%
0.00%
Q1 2016$135,000
+87.5%
28,266
+74.8%
0.00%
Q4 2015$72,00016,1710.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q3 2018
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders